|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 20.81 USD | -0.90% |
|
-0.29% | +116.55% |
| 07-30 | B. Riley Adjusts Anika Therapeutics Price Target to $21 From $18, Maintains Buy Rating | MT |
| 07-30 | Barrington Raises Price Target on Anika Therapeutics to $21 From $17, Keeps Outperform Rating | MT |
| Market Cap | 278M 240M 225M 206M 385M 26.34B 386M 2.67B 1.03B 13.49B 1.05B 1.02B 42.96B | P/E 2026 * |
-2,081x | P/E 2027 * | 44.8x |
|---|---|---|---|---|---|
| Enterprise Value | 278M 240M 225M 206M 385M 26.34B 386M 2.67B 1.03B 13.49B 1.05B 1.02B 42.96B | EV / Sales 2026 * |
2.28x | EV / Sales 2027 * | 2.17x |
| Free-Float |
79.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ANIK | Delayed | |
CBOE
| ANIK | Real-time | |
|
Deutsche Boerse AG
| AKP | Delayed | |
|
Börse Stuttgart
| AKP | Delayed | |
|
Berne S.E.
| AKP | End-of-day quote | |
|
Boerse Muenchen
| AKP | Real-time |
Last Transcript : Anika Therapeutics, Inc.
| 1 day | -0.90% | ||
| 1 week | -0.29% | ||
| Current month | -0.29% | ||
| 1 month | -2.85% | ||
| 3 months | +43.72% | ||
| 6 months | +47.38% | ||
| Current year | +116.55% |
| 1 week | 20.76 |  | 21.66 |
| 1 month | 20.13 | | 22.88 |
| Current year | 9.01 | | 22.88 |
| 1 year | 8.37 | | 22.88 |
| 3 years | 7.87 | | 29.12 |
| 5 years | 7.87 | | 45.81 |
| 10 years | 7.87 | | 75.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Griffin
CEO | Chief Executive Officer | 40 | 2026-01-31 |
Dawn J. Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 2023-08-31 |
Mira Leiwant
CTO | Chief Tech/Sci/R&D Officer | - | 2019-10-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheryl Blanchard
CHM | Chairman | 61 | 2026-01-31 |
John Henneman
CHM | Chairman | 64 | 2024-02-23 |
Stephen Richard
BRD | Director/Board Member | 63 | 2020-09-02 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/4/26 | Buy | Director | 1,000 | 0.0075% | ||
| 6/3/26 | Exercice | Chief Executive Officer | 29,449 | 0.2213% | ||
| 5/1/26 | Buy | Director | 5,000 | 0.0373% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | -0.29% | +132.77% | +20.57% | 278M | |
| -0.42% | -1.84% | -18.51% | +7.61% | 187B | |
| +1.15% | +3.88% | +1.37% | +17.82% | 120B | |
| -1.86% | +2.27% | +13.15% | +85.74% | 63.15B | |
| -1.80% | -4.74% | +14.24% | +47.63% | 51.75B | |
| -1.54% | -1.79% | -3.98% | -30.82% | 50.32B | |
| -2.02% | -3.47% | +9.18% | -16.21% | 33.17B | |
| 0.00% | +4.45% | - | - | 32.1B | |
| -0.81% | -0.33% | +35.59% | -15.82% | 23.93B | |
| -1.81% | -8.41% | -12.30% | +9.23% | 22.99B | |
| Average | -1.00% | -0.57% | +19.06% | +13.97% | 58.56B | |
| Weighted average by Cap. | -0.61% | -0.64% | -1.86% | +16.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 122M 105M 98.87M 90.26M 169M 11.56B 169M 1.17B 453M 5.92B 459M 449M 18.86B | 129M 111M 104M 94.92M 178M 12.16B 178M 1.23B 477M 6.23B 483M 472M 19.83B |
| Net income | -67.5K -58.05K -54.6K -49.84K -93.21K -6.38M -93.51K -647K -250K -3.27M -253K -248K -10.41M | 6.42M 5.52M 5.2M 4.74M 8.87M 607M 8.9M 61.6M 23.81M 311M 24.12M 23.6M 991M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$20.81 | -0.90% | 96,357 |
| 26-09-03 | US$21.00 | -2.55% | 57,721 |
| 26-09-02 | US$21.55 | +2.08% | 77,746 |
| 26-09-01 | US$21.11 | +1.15% | 90,126 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANIK Stock
Select your edition
All financial news and data tailored to specific country editions
